As the legalization of cannabis for recreational use becomes a reality in Canada, it is important for the government to continue supporting social enterprises like High Hopes that are focused on providing affordable, high-quality medical cannabis to those who need it.

Cannabis has been shown to be effective in treating a wide range of medical conditions, including chronic pain, seizures, and anxiety. However, the cost of medical cannabis can be prohibitively expensive for many individuals, particularly those on fixed incomes or with limited access to healthcare.

This is where social enterprises like High Hopes come in. By offering affordable medical cannabis options, High Hopes is able to provide access to this important medication for those who might not otherwise be able to afford it. Additionally, by offering cannabis substitution options, High Hopes is able to help individuals reduce their reliance on potentially harmful prescription medications and make the switch to a safer, more natural alternative.

The government of Canada has a responsibility to support initiatives like High Hopes that are working to improve access to affordable, high-quality medical cannabis. This can be done through a variety of measures, such as providing funding for research and development, offering tax breaks or other financial incentives, and creating regulations and policies that support social enterprises like High Hopes.

In addition to the benefits for individual patients, supporting social enterprises like High Hopes can also have positive impacts on the broader healthcare system. By providing affordable, high-quality medical cannabis options, these enterprises can help reduce the burden on the healthcare system by providing an alternative to expensive prescription medications.

Overall, the government of Canada has a responsibility to support initiatives like High Hopes that are working to improve access to affordable, high-quality medical cannabis. By doing so, the government can help ensure that individuals have access to the medications they need to improve their health and well-being, while also supporting the growth of innovative, socially responsible enterprises.